These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Patient tolerance to interferon: clinical and laboratory assessments. Fischl MA Med Clin North Am; 1986 May; Suppl():41-5. PubMed ID: 2426535 [TBL] [Abstract][Full Text] [Related]
8. Interferon therapy. Alexander MC NITA; 1987; 10(1):40-2. PubMed ID: 2434885 [No Abstract] [Full Text] [Related]
9. The chimpanzee as a model to test the side effects of human interferons. Schellekens H; de Reus A; vd Meide PH J Med Primatol; 1984; 13(5):235-45. PubMed ID: 6210368 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacological aspects of interferon therapy in man. Billiau A Acta Microbiol Acad Sci Hung; 1981; 28(3):257-62. PubMed ID: 6171139 [No Abstract] [Full Text] [Related]
11. [Problems in the clinical evaluation of interferon]. Zanussi C Ann Ist Super Sanita; 1987; 23(4):779-85. PubMed ID: 2454600 [No Abstract] [Full Text] [Related]
12. [Complications in interferon therapy for chronic hepatitis C]. Arase Y Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):519-22. PubMed ID: 15359854 [No Abstract] [Full Text] [Related]
13. Interferon: pharmacokinetics and toxicity. Scott GM Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):91-107. PubMed ID: 6183699 [TBL] [Abstract][Full Text] [Related]
14. Effect of interferon therapy on heart rate and sympathetic nervous system. Yamamoto T; Tsuchihashi T; Hayashi J; Kashiwagi S Fukuoka Igaku Zasshi; 1998 Jul; 89(7):207-15. PubMed ID: 9745188 [TBL] [Abstract][Full Text] [Related]
15. Prediction models for feverishness developed during interferon therapy of chronic hepatitis C patients. Uesawa Y; Motege E; Dai Y; Ishii K; Mohri K Pharmazie; 2010 Feb; 65(2):114-6. PubMed ID: 20225655 [TBL] [Abstract][Full Text] [Related]